🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Explore the latest melanoma therapies and the significant role of anti-LAG3 antibodies with Dr. Miller David M. Miller MD, PhD, FAAD! Learn more about this activity: ow.ly/13yc50Nu3fm #SkinCancerAwareness #Melanoma #immunotherapy #CME #medicaleducation #medlearninggroup

David Miller & Sophia Shalhout with MassGeneral Medicine & Mass Eye and Ear, will be giving a session presentation on “StoryboardR: An R package and Shiny application designed to visualize real-world data from clinical patient registries” at #RMed2023. #Rstats ➡️ events.linuxfoundation.org/r-medicine/

Looking forward to hearing from our esteemed panelists Kenneth Y. Tsai and Dr. Michael Migden along with co-chair Dr. Michael K Wong in our upcoming MedscapeLIVE event: na.eventscloud.com/website/51593/ It should make for a great discussion.

Excited for the upcoming #RMed2023. Always one of my favorite events of the year. Looking forward to presenting StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries with @SophiaShalhout. #Rstats R Medicine

You still have time to join us live from #ASCO23! Learn and earn credit from social media. Watch the stream now.

Looking forward to discussing the latest developments in the treatment of #NMSC with Dr. Vishal Patel of GW med at tonight’s Med Learning Group event.

🎉 The excitement is building as we count down for our Complimentary Virtual CME/CNE Program on NMSC! Join Dr. Miller David M. Miller MD, PhD, FAAD and Dr. Patel TONIGHT at 7:30 PM EST! Register Now: ow.ly/HZUo50OBUVO #oncology #MedTwitter #VirtualEvent #CME #CNE #MedLearningGroup

Thx to Laura Ferris, Nikhi Khushalani, Kevin Emerick, Sonia Cohen, Sameer Gupta, Ryan Sullivan, Linette Bosques, Emily Kim, MD, @BhatiaS_MD, @MunTheLoon & David M. Miller MD, PhD, FAAD for another great Journal Club discussion of the USPSTF recs re: skin cancer screening jamanetwork.com/journals/jama/…

Explore Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer with leading experts Dr. Miller David M. Miller MD, PhD, FAAD and Dr.Patel! Register now for Monday, June 26th at 7:00 PM ET: medlearninggroup.com/cme-programmin… #Virtual #CME #Immunotherapy #MedTwitter #MedLearningGroup

Is adjuvant anti-PD1 ready for the clinic for patients with Merkel Cell Carcinoma? Check out the latest #JoCO Perspectives on the Science. journalofcutaneousoncology.io/perspectives/v… #MCC #Immunotherapy #Cancer

What’s the latest data on Mohs surgery for invasive melanoma? Check out this Perspectives on the Science piece in #JoCO journalofcutaneousoncology.io/perspectives/v… #Melanoma #Cancer #mohs #derm

Does more frequent surveillance imaging improve patient outcomes in stage III melanoma? Check out the Perspectives on the Science article by Kevin Emerick and David M. Miller MD, PhD, FAAD doi.org/10.59449/joco.….

Moh's surgery is one option for patients with invasive melanoma. Check out this Perspectives on the Science article to read more about it: doi.org/10.59449/joco.…

Merkel Cell Carcinoma is a rare skin cancer with the potential for recurrence and poor patient outcomes. Check out this Perspectives on the Science article that examines the role of post-operative immunotherapy for MCC: doi.org/10.59449/joco.…

Is routine skin cancer screening recommended for all? Check out this Perspectives on the Science article to find out more: doi.org/10.59449/joco.… #skincancer

Tumor-Infiltrating lymphocyte #TIL therapy is a new FDA-approved option for patients with advanced #melanoma. In this #JoCO editorial, the authors reflect on the recent approval of the first cellular therapy for melanoma. doi.org/10.59449/joco.…

New in Perspectives on the Science (JoCO): "The Evolving Role of Circulating Tumor DNA in Merkel Cell Carcinoma" explores how ctDNA is reshaping disease monitoring, prognosis, and potentially guiding treatment. 🧬 Read the full piece: journalofcutaneousoncology.io/perspectives/v… #MCC #ctDNA #JoCO

Hot off the press in Perspectives on the Science (JoCO): "Nivolumab Plus Ipilimumab in Merkel Cell Carcinoma" delves into dual checkpoint blockade and its promising impact on MCC outcomes. 👉 Read more: journalofcutaneousoncology.io/perspectives/v… #MCC #Immunotherapy #NivoIpi #DermOnc #JoCO